About
Treos Bio Limited is a clinical-stage company developing off-the-shelf peptide-based active cancer immunotherapies that stimulate immune responses across genetically diverse patient populations without the need for tumor biopsy.
Explore Treos Bio Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.